Back
Fulcrum Therapeutics, Inc. Stock Price Chart
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
48
FULC
Fulcrum Therapeutics, Inc.
Last Price:
$10.11
Seasonality Move:
-11.85%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing slight selling pressure.
Fulcrum Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.13 | Sell |
| 20-day SMA: | 12.14 | Sell |
| 50-day SMA: | 10.5 | Sell |
| 200-day SMA: | 7.49 | Buy |
| 8-day EMA: | 10.94 | Sell |
| 20-day EMA: | 11.31 | Sell |
| 50-day EMA: | 10.67 | Sell |
| 200-day EMA: | 8.2 | Buy |
Fulcrum Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 40.12 | Sell |
| Chaikin Money Flow: | -382897 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.95 - 13.11) | Sell |
| Bollinger Bands (100): | (7.2 - 11.18) | Buy |
Fulcrum Therapeutics, Inc. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Fulcrum Therapeutics, Inc. Stock
Is Fulcrum Therapeutics, Inc. Stock a Buy?
-
Fulcrum Therapeutics, Inc. share price is 9.98 while FULC 8-day simple moving average is 11.13, which is a Sell signal.
-
The stock price of FULC is 9.98 while Fulcrum Therapeutics, Inc. 20-day SMA is 12.14, which makes it a Sell.
-
Fulcrum Therapeutics, Inc. 50-day simple moving average is 10.50 while FULC share price is 9.98, making it a Sell technically.
-
FULC stock price is 9.98 and Fulcrum Therapeutics, Inc. 200-day simple moving average is 7.49, creating a Buy signal.
FULC Technical Analysis vs Fundamental Analysis
Sell
48
Fulcrum Therapeutics, Inc. (FULC)
is a Sell
Is Fulcrum Therapeutics, Inc. a Buy or a Sell?
-
Fulcrum Therapeutics, Inc. stock is rated a SellThe current Fulcrum Therapeutics, Inc. [FULC] share price is $9.98. The Score for FULC is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Fulcrum Therapeutics, Inc. Stock Info
Market Cap:
540.1M
Price in USD:
9.98
Share Volume:
1M
Fulcrum Therapeutics, Inc. 52-Week Range
52-Week High:
15.74
52-Week Low:
2.32
Sell
48
Fulcrum Therapeutics, Inc. (FULC)
is a Sell
Fulcrum Therapeutics, Inc. Share Price Forecast
-
What is the Fulcrum Therapeutics, Inc. stock price today?The Fulcrum Therapeutics, Inc. stock price is 9.98 USD today.
-
Will FULC stock go up or go down?Fulcrum Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Fulcrum Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fulcrum Therapeutics, Inc. is overvalued.
Is Fulcrum Therapeutics, Inc. Stock a Buy?
-
Fulcrum Therapeutics, Inc. share price is 9.98 while FULC 8-day exponential moving average is 10.94, which is a Sell signal.
-
The stock price of FULC is 9.98 while Fulcrum Therapeutics, Inc. 20-day EMA is 11.31, which makes it a Sell.
-
Fulcrum Therapeutics, Inc. 50-day exponential moving average is 10.67 while FULC share price is 9.98, making it a Sell technically.
-
FULC stock price is 9.98 and Fulcrum Therapeutics, Inc. 200-day simple moving average is 8.20, creating a Buy signal.
Fundamental Analysis of Fulcrum Therapeutics, Inc.
Is Fulcrum Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.17 per share.
Technical Analysis of Fulcrum Therapeutics, Inc.
Should I short Fulcrum Therapeutics, Inc. stock?
-
FULC Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Fulcrum Therapeutics, Inc. is a Sell
-
Fulcrum Therapeutics, Inc. Relative Strength Index (RSI) is 40.12, which suggest Fulcrum Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Fulcrum Therapeutics, Inc. is (9.95 - 13.11), which suggest Fulcrum Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Fulcrum Therapeutics, Inc. is (7.2 - 11.18), which suggest Fulcrum Therapeutics, Inc. is a Buy
* Fulcrum Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.